Thomas Newsom-Davis

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Vasileios Angelis et al. · The Lancet · 2020 · 1.1K citations · Full text

Covid-19 Mortality, Epidemiology, Cancer Epidemiology +12

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer

David J. Pinato, Sarah Howlett, Diego Ottaviani et al. · JAMA Oncology · 2019 · 564 citations · Full text

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 123 citations · Full text

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

Mark Tuthill, Antonella Montinaro, Julia Zinngrebe et al. · Oncogene · 2014 · 74 citations · Full text

Immunology, Immune Checkpoint Inhibitor, Trail-r2-specific Antibodies +9

Time-Dependent COVID-19 Mortality in Patients With Cancer

Mark Bower, Ramón Salazar, Alexia Bertuzzi et al. · JAMA Oncology · 2021 · 70 citations · Full text